Submit a project
0 results

    Partners forHealthcare

    We believe in abetter future forpeople and theplanet.

    We're investing in a better future for people and the planet.

    At Sofinnova Partners, we focus on breakthrough innovations that have the potential to solve the world's most pressing problems. Experience, agility, and diverse points of view fuel our ability to thrive in a complex environment.

    Founded in 1972, Sofinnova Partners has backed more than 500 companies over 50 years, creating market leaders around the globe. Today, Sofinnova Partners has over €4 billion under management.

    "Partners for Life" is a cornerstone of our identity: we build lasting relationships with trust and transparency. We invest in entrepreneurs who strive to transform biopharma, medtech, digital medicine, agriculture and industrial processes with cutting-edge science that will contribute to people's health and well-being.

    Our Funds

    Sofinnova Partners is active across the entire value chain of life sciences investments, from seed to later-stage, with a focus on healthcare and sustainability. Each of our funds is a manifestation of our ability to recognize opportunity and unlock its potential with a dedicated team and a tailored strategic approach.

    SofinnovaCapital

    The Sofinnova Capital Strategy is our flagship fund, investing as founding or lead investor in early-stage biopharma and medtech start-ups developing groundbreaking therapeutic technologies.

    SofinnovaMD Start

    The Sofinnova MD Start Strategy is our in-house medtech accelerator focused on creating and launching early-stage medtech companies through hands-on company building.

    SofinnovaCrossover

    The Sofinnova Crossover Strategy invests in growth-stage biotech and medtech companies that have clinically validated their technologies and are preparing for commercialization.

    SofinnovaIndustrial Biotech

    Our Industrial Biotech Strategy invests in early-stage sustainable companies across the agriculture, chemicals, food and materials sectors.

    SofinnovaTelethon

    The Sofinnova Telethon Strategy makes early-stage investments in leading Italian science for the benefit of patients around the world.

    SofinnovaDigital Medicine

    Our Digital Medicine Strategy backs early-stage techbio and healthtech start-ups at the intersection of biology, data, and computation.

    SofinnovaBiovelocita

    The Sofinnova Biovelocita Strategy is our biotech accelerator, partnering with leading research organizations to create and build European biotech start-ups.

    • 1972

      Established

    • 50

      Years of Experience

    • 500+

      Companies Backed

    • 4+ Bn

      Euros in Assets Under Management

    • 7

      Investment Strategies

    "We are known for being company creators. We continue to do what we know. Our strategy has evolved, but has remained consistent."

    "If you treat patients, you save lives, ultimately this is going to be good for investors. We believe that by backing companies, whether early stage or later stage, that bring a product to patients — ultimately this translates into financial return."

    “I joined Sofinnova Partners because first of all, they have a fantastic brand in Europe, but it's easy to see it is a very strong partnership. They're loyal to each other and everyone knows they treat entrepreneurs well.”

    Graziano Seghezzi

    Managing Partner, Sofinnova Partners

    Antoine Papiernik

    Chairman & Managing Partner, Sofinnova Partners

    Henrijette Richter

    Managing Partner, Sofinnova Partners

    Latest News